1α,25-Dihydroxyvitamin D3Increases Transforming Growth Factor and Transforming Growth Factor Receptor Type I and II Synthesis in Human Bone Cells
- 29 October 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 239 (3) , 734-739
- https://doi.org/10.1006/bbrc.1997.7544
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Role of Cytokines and Growth Factors as Mediators of the Effects of Systemic Hormones at the Bone Local LevelCritical Reviews™ in Eukaryotic Gene Expression, 1995
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1993
- 1α,25‐Dihydroxyvitamin D3 rapidly increases nuclear calcium levels in rat osteosarcoma cellsJournal of Cellular Biochemistry, 1993
- Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression.Proceedings of the National Academy of Sciences, 1993
- Vitamin D and calcium transportKidney International, 1991
- Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.The Journal of cell biology, 1990
- 1,25-Dihydroxyvitamin D3Inhibits Transcription of Type I Collagen Genes in the Rat Osteosarcoma Cell Line ROS 17/2.8*Endocrinology, 1989
- In VivoStimulation of Bone Formation by Transforming Growth Factor-βEndocrinology, 1989
- The Molecular Cloning of the Complementary Deoxyribonucleic Acid for Bovine Vitamin D-Dependent Calcium-Binding Protein: Structure of the Full-Length Protein and Evidence for Homologies with Other Calcium-Binding Proteins of the Troponin-C Superfamily of ProteinsMolecular Endocrinology, 1989
- Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitroJournal of Endocrinology, 1985